Animal Model Market Synopsis:
Animal Model Market Size Was Valued at USD 2.87 Billion in 2023, and is Projected to Reach USD 4.11 Billion by 2032, Growing at a CAGR of 8.6 % From 2024-2032.
Animal Model Market is the global market that extends to the use of animals in disease development, treatment discovery, Drug Testing and understanding biological processes. Animal models refers to living animals most preferably mice, rats, monkeys, dogs, pigs and others intended to simulate human diseases or states. These models are of paramount importance to scientific investigations in medicine; for example in cancer, neurological disorders, immunology, and cardiovascular diseases, and toxicology, stem cell biology and genetic disorders.A brief discussion of Animal usage in biomedical research is important in the context of the preclinical stage of drug development aims at testing necessary treatments on animals in order to determine their safety efficiencies before being utilized on human beings. They also help in explaining the causes of diseases, experiments ofdevices that are new in the market, and the impacts that treatments have on systems in the body. The global market is growing due to the development in productivity in pharma and biotechnology market, the requirements by the authorities for pre clinical tests etc and the up rising prevalence of diseases like cancer, cardiovascular disorders and diabetes etc. However, there is an ethical controversy over animal testing and finally, invention of new techniques are the two vital threats exist in this industry.
The Animal Model Market is a relatively young segment of the global life sciences industry, which is continually expanding due to the rising need for proving efficacy and safety of investigational drugs and therapies. These include rodents including mice and rats, non human primates, dogs and pigs which mimic diseases or biological states observed in humans. Invaluable models they are when it comes to studying how diseases occur, and how different methods of treatment affect the illness before using animals in experiments. This market is crucial for the development of pharmaceuticals, biotechnology and academic research proponents, and the certainty that new medical products are safe.
The market is growing at a very healthy rate driven by several factors which include; enhanced investments in the R & D sector, global rising incidence of almost all chronic diseases including cancer, cardiovascular diseases, diabetes and neurodegenerative disorders, broadening requirement of bio testing in drugs and vaccines. In particular, the growth of the trends toward individualized medicine and immunotherapy is stimulating the demand for GM animals, which reproduce certain human genetic features and pathological states in vivo. Furthermore, further regulations have been imposed on preclinical toxic studies to be practiced on animals thus increasing demand for models in the pharmaceutical and biotechnology industries.
Based on the region, the North American market has the maximum share in the animal model market due to factors such as well-developed and more stringent health care systems and pharmaceutical research environment and well-regulated governments’ policies which require testing on animals for new drugs or treatments. Europe is also a major share of the market mainly due to the constant demand in the research laboratories and in drug development organizations. However, Asia-Pacific is expected to grow at the fastest rate due to growing investment in biomedical research, improving healthcare infrastructure, and rapidly growing biotech and pharmaceutical sectors in countries such as China, India and Japan.
Animal Model Market Trend Analysis:
Growing Demand for Genetically Modified Animal Models Drives Market Innovation
- Currently the animal model market is enjoying innovation triggered by the rising need to develop genetically modified animals. These include transgenic and knockout animals, which are being used with increasing regularity in preclinical research to model human diseases at the Molecular and genetic level. The knock in and out technique also makes it possible for researchers to understand the impact of a particular gene on a disease or how an animal responds to medication and the treatment given to him because the physiology of an animal is most closely related to that of a human being than to any other creature.
- This trend has been especially apparent in disciplines such as oncology, neurology, immunology, and genetics, where investigators need unique disease models at the molecular level to learn about disease development and to treat the disease with targeted therapies. For instance, genetically modified animals are being used in context with cancer research by developing animals bearing tumor, similar to human biology. Likewise in immunology humanized models meaning animals carry functional human immune system components are helping better understand immune response and vaccine production. The increasing trends associated with precise medicines plus customized treatments amplify also the application of the models, due to enhancing impacts in pharmaceutical innovation, testing of toxicity plus development of vaccines.
Precision Medicine Fuels Demand for Genetically Modified and Humanized Animal Models
- Interestingly, precision medicine is actually cited to be very much responsible for the escalating need for GM as well as humanized animal models. These models are gradually finding their way in the experimental studies which aim to reflect the condition of human diseases at genetic and molecular levels to enhance credibility of trials of potential therapeutic interventions and drug development. To build animals that are similar to humans with regards to genetics and functioning, scientists have developed mouse models that have human genes or have human like immune systems, and vice versa, which helps you understand how diseases occur and also how those diseases can be treated.
- The drive toward the use of molecular targeted therapies and the development of individualized treatment that are built on genetics is also encouraging renewed use of animal models that can reproduce variations in patients’ genes. This approach is has been more acutely pronounced in oncotherapy and pathogen immunology, where humanised genetically modified mice models are employed to observe the impact of specified gene mutation for tumour, or the immune response to the cancer, auto-immune diseases and infections, respectively. An increase in focus on pharmacogenomics and aggressiveness in personalized drugs and therapies of the disease means that genetic modification of animal models and humanization of animal models are increasingly important tools for drug discovery, biomarker development and the generation of effective individual treatments.
Animal Model Market Segment Analysis:
Animal Model Market is Segmented on the basis of Type, Application, End User, and Region
By Type, mice and guinea pigs segment is expected to dominate the market during the forecast period
- Further, out of all these segments the mice and guinea pigs segment is expected to lead the Animal Model Market at least during the forecast timeframe because animals such as mice and guinea pigs etc are in high demand from the preclinical researches. Mice even more are the most common animals used due to their genetic relationship to humans making them suitable model organisms for understanding human diseases, genetic diseases and even a drugs powers. These mice are easy to genetically manipulate because they are small, have short life spans, and hence genetically manipulating them does not pose difficultly Owing to the above characteristics they have found basic and applied uses in fields such as oncology, neurology immunology and cardiology among others
- However, like mice, guinea pigs occupy a large niche in the animal model market, as they are often used in immunology, toxicology and infectious diseases experiments. Its immune system is closer to human than a mouse, which makes it suitable for use in vaccine and drug development, researching respiratory diseases among human beings among others. That is concerning with vaccines; especially with severe diseases such as tuberculosis and pneumonia make them relevant in both academic and industrial research. For this reason, both mice and guiena pigs are expected to reported to continued to command a large market share due to their popularity as they are used in most fields of research.
By Application, Cancer segment expected to held the largest share
- The cancer application segment is anticipated to be dominating the Animal Model Market throughout the forecast period, due to the growing incidence of cancer globally and the indispensability of animal models in cancer diagnosis and drug design. NK cell animals are widely used for basic research focused on tumor biology, metastatic processes and resistance to drugs, genetically altered mice and humanized mice. These models facilitate the study of potential risks and effectiveness of new chemotherapy, immunotherapy, targeted therapy and gene therapy treatment plans before proceeding to human trials.
- Besides the providing therapeutic advantage for various types of cancer like breast cancer, lung cancer, colon cancer and leukemia, animal models are also crucial in uncovering genetic and molecular basis of carcinogenesis and cancer progression. The calls for more specialized cancer treatments also include precision medicine and therefore, require models that can mimic an individual’s tumors. This makes the cancer segment one of the largest and most significant growth stimulator in the animal model market because continue to attract a lot of research attention in the fight against cancer across the world.
Animal Model Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
- North America is expected to hold the largest share in the Animal Model Market during the given timeframe because of improvements in the biomedical research sector, advanced healthcare system, and the development of pharmaceutical and biotechnology sectors. For instance, ranked in a top position, the United States remains a world’s leading country for life sciences industry with massive spending in drug research, biotechnology solutions, and trials. This means that North American countries are major consumer of animal models for diverse research fields including oncological, neurological, immunological and toxicological research. The location of many of the world’s premier pharmaceutical and biotech organizations, associated with first-rate research institutions and academic institutions increases the need for animal models for preclinical trial and drug improvement.
- Besides, agency support and the ethical guideline provided by the like the U.S food and drug administration (FDA) and Health Canada advocate for the use of animal models in research or preclinical drug development. North America also avails outsourced animal model based services from Contract Research Organizations (CROs) of pharma industries. Personalized medicine, gene therapies and other advanced biologics that are under development in the region also increase demand for specific animal models, which include humanized models and genetically modified animals. Taking into consideration the increased concern for novel research and clinical trials, North America is anticipated to remain the leading region throughout the forecast period in the animal model market.
Active Key Players in the Animal Model Market:
- Biocytogen Pharmaceuticals (China)
- Charles River Laboratories International, Inc. (USA)
- Covance, Inc. (USA)
- Crown Bioscience, Inc. (USA)
- Envigo (USA)
- Eurofins Scientific (Luxembourg)
- Harlan Laboratories (USA)
- Harvard Bioscience, Inc. (USA)
- Jiangsu Suyin Medical Devices Co., Ltd. (China)
- Kanglin Pharmaceutical Co., Ltd. (China)
- LABORATORIES MERCK S.A.S. (Germany)
- Pharmalex (USA)
- Shanghai Lihua Pharmaceutical Co., Ltd. (China)
- Sichuan Langhua Pharmaceutical Co., Ltd. (China)
- Taconic Biosciences, Inc. (USA)
- The Jackson Laboratory (USA)
- WuXi AppTec (China/USA)
- Zhejiang Kangsino Pharmaceutical Co., Ltd. (China)
- Other Active Players
|
Animal Model Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 2.87 Billion |
|
Forecast Period 2024-32 CAGR: |
8.6 % |
Market Size in 2032: |
USD 4.11 Billion |
|
Segments Covered: |
By Type |
|
|
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Frequently Asked Questions :
The forecast period in the Animal Model Market research report is 2024-2032.
